Linking multiple preclinical fibrosis models through gene expression provides a comprehensive tool for comparing the molecular profiles of fibrosis models across different organs, allowing for a deeper understanding of disease progression in various tissue types. Aragen’s FibroPanel™ enables this approach by focusing on key genes involved in fibrosis, such as TGF-β, cytokines, and tissue remodeling factors. FibroPanel™ provides critical insights into disease mechanisms, helps identify potential biomarkers, and uncovers new therapeutic targets. This powerful platform accelerates drug development, facilitates drug efficacy testing, and supports the creation of targeted treatments, offering significant advantages in fibrosis research. The included gene collection highlights critical factors like TGF-β and its controlled genes, cytokines, and tissue remodeling genes, which are shown in the graphs below.
FibroPanel TM Gene Expression Data:
FibroPanelTM is a collection of genes known to be involved in fibrosis, including TGF-β, TGF-β controlled genes, cytokines, and tissue remodeling genes
